Mark Scarafone Senior Vice President and Health & Benefits Leader Radnor, PA Jake Delman Senior Consultant Washington, DC The information contained herein and the statements expressed are of a general nature and are not intended to address the circumstances of any particular individual or entity
A 2021 review in the International Journal of Pharmaceutics confirmed that lyophilized peptide formulations lose significant potency when exposed to temperatures above 25 C for more than 48 hours [1]
The target of miR-151-5p that may alleviate atherosclerosis is unclear and requires further study
Singh Y, Meher JG, Raval K, Khan FA, Chaurasia M, Jain NK, et al
References Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, et al